Literature DB >> 19436054

HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase.

Andrew N Harman1, Marianne Kraus, Chris R Bye, Karen Byth, Stuart G Turville, Owen Tang, Sarah K Mercier, Najla Nasr, Josh L Stern, Barry Slobedman, Christoph Driessen, Anthony L Cunningham.   

Abstract

Dendritic cells (DCs) play a key role in the pathogenesis of HIV infection. HIV interacts with these cells through 2 pathways in 2 temporal phases, initially via endocytosis and then via de novo replication. Here the transcriptional response of human DCs to HIV-1 was studied in these phases and at different stages of the virus replication cycle using purified HIV-1 envelope proteins, and inactivated and viable HIV-1. No differential gene expression was detected in response to envelope. However, more than 100 genes were differentially expressed in response to entry of viable and inactivated HIV-1 in the first phase. A completely different set of genes was differentially expressed in the second phase, predominantly in response to viable HIV-1, including up-regulation of immune regulation genes, whereas genes encoding lysosomal enzymes were down-regulated. Cathepsins B, C, S, and Z RNA and protein decreased, whereas cathepsin L was increased, probably reflecting a concomitant decrease in cystatin C. The net effect was markedly diminished cathepsin activity likely to result in enhanced HIV-1 survival and transfer to contacting T lymphocytes but decreased HIV-1 antigen processing and presentation to these T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436054      PMCID: PMC2710958          DOI: 10.1182/blood-2008-12-194845

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  Activity and subcellular distribution of cathepsins in primary human monocytes.

Authors:  Andrea Greiner; Alfred Lautwein; Herman S Overkleeft; Ekkehard Weber; Christoph Driessen
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

4.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.

Authors:  G K Geiss; R E Bumgarner; M C An; M B Agy; A B van 't Wout; E Hammersmark; V S Carter; D Upchurch; J I Mullins; M G Katze
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

5.  Impact of viral infection on the gene expression profiles of proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF.

Authors:  Maryanne T Vahey; Martin E Nau; Linda L Jagodzinski; Jake Yalley-Ogunro; Michele Taubman; Nelson L Michael; Mark G Lewis
Journal:  AIDS Res Hum Retroviruses       Date:  2002-02-10       Impact factor: 2.205

6.  HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.

Authors:  Elena Izmailova; Frederic M N Bertley; Qian Huang; Norbert Makori; Christopher J Miller; Richard A Young; Anna Aldovini
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

7.  Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.

Authors:  Hannah Yuan Chen; Michele Di Mascio; Alan S Perelson; David D Ho; Linqi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

8.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

9.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

10.  Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication.

Authors:  Ashleigh Hodges; Katherine Sharrocks; Mariola Edelmann; Dilair Baban; Arnaud Moris; Olivier Schwartz; Hal Drakesmith; Kay Davies; Benedikt Kessler; Andrew McMichael; Alison Simmons
Journal:  Nat Immunol       Date:  2007-05-13       Impact factor: 25.606

View more
  32 in total

1.  Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses.

Authors:  Fabien P Blanchet; Arnaud Moris; Damjan S Nikolic; Martin Lehmann; Sylvain Cardinaud; Romaine Stalder; Eduardo Garcia; Christina Dinkins; Florence Leuba; Li Wu; Olivier Schwartz; Vojo Deretic; Vincent Piguet
Journal:  Immunity       Date:  2010-05-06       Impact factor: 31.745

Review 2.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

3.  HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.

Authors:  Natalia J Reszka-Blanco; Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.

Authors:  Najla Nasr; Abdullateef A Alshehri; Thomas K Wright; Maryam Shahid; Bonnie M Heiner; Andrew N Harman; Rachel A Botting; Karla J Helbig; Michael R Beard; Kazuo Suzuki; Anthony D Kelleher; Paul Hertzog; Anthony L Cunningham
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

5.  HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1.

Authors:  Andrew N Harman; Najla Nasr; Alexandra Feetham; Ani Galoyan; Abdullateef A Alshehri; Dharshini Rambukwelle; Rachel A Botting; Bonnie M Hiener; Eve Diefenbach; Russell J Diefenbach; Min Kim; Ashley Mansell; Anthony L Cunningham
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 6.  Myeloid dendritic cells in HIV-1 infection.

Authors:  Nina Derby; Elena Martinelli; Melissa Robbiani
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

Review 7.  Gene Expression: the Key to Understanding HIV-1 Infection?

Authors:  Melinda Judge; Erica Parker; Denise Naniche; Peter Le Souëf
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

Review 8.  Systems biology-based approaches to understand HIV-exposed uninfected women.

Authors:  Adam Burgener; J Sainsbury; F A Plummer; T Blake Ball
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

9.  HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production.

Authors:  Andrew N Harman; Joey Lai; Stuart Turville; Shamith Samarajiwa; Lachlan Gray; Valerie Marsden; Sarah K Mercier; Sarah Mercier; Kate Jones; Najla Nasr; Arjun Rustagi; Helen Cumming; Heather Donaghy; Johnson Mak; Michael Gale; Melissa Churchill; Paul Hertzog; Anthony L Cunningham
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

10.  Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes.

Authors:  Stéphanie Durand; Xuan-Nhi Nguyen; Jocelyn Turpin; Stephanie Cordeil; Nicolas Nazaret; Séverine Croze; Renaud Mahieux; Joël Lachuer; Catherine Legras-Lachuer; Andrea Cimarelli
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.